Figure 4.
Immunological parameters as possible predictive markers for chemoradioimmunotherapy with IFN. Data of FACS analysis, granzyme B release and IL-2 analysis were correlated with patients' OS and/or DFS with Kaplan–Meier methods. For statistical data, see Supplementary Table S2.